Alpha memo: resveratrol exercise training cross-context signal

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• The memo could briefly note that Receipt 2 reports a ~45% lower VO2max gain (verifiable from excerpt) but this is the well-known Gliemann et al. 2013 result — already implied by the data but could be made more explicit.
• No meta-analytic or systematic review framing needed; the single-pair contrast is the intended scope, but a one-line note acknowledging that other resveratrol + exercise trials exist (with mixed outcomes) would sharpen the falsifiability discussion.

Reviewer note

The memo presents a clean, bounded two-receipt contrast: resveratrol + high-intensity training in mice (intestinal inflammation/ferroptosis attenuated, 2023) vs. resveratrol + high-intensity training in older men (VO2max blunting, 2013). Both receipts are real, correctly cited, and present in the source bundle with matching DOIs, titles, and abstracts. The ~45% lower VO2max gain in the resveratrol group is directly supported by the Receipt 2 excerpt. The cross-context split framing (intestinal protective in mice, cardiovascular blunting in aged men) is appropriately hedged with 'appears to' and 'may blunt' language, and the memo explicitly acknowledges species/dose/endpoint confounders. Limitations are unusually specific and material: dose non-equivalence across species, endpoint mismatch (intestinal vs cardiovascular), age of Receipt 2, and a clearly articulated falsifier (combined endpoint trial). Title/source alignment is clean — resveratrol, exercise training, cross-context signal all map directly to the two receipts. The memo stays within alpha-memo scope: it surfaces a single research signal, does not overclaim clinical/policy implications, and invites falsification rather than treating the split as settled. Research question quality is 4 rather than 5 because the question is implicit rather than stated as a formal PICO, but for an alpha-memo this is appropriate. Synthesis is adequate (4): the two receipts are integrated into a coherent contrast argument rather than listed in isolation. Claim-evidence alignment is strong (4) with appropriate hedging. Limitations are the standout — specific, material, and falsifiability-oriented (5). Gaps are reasonable and actionable (4). Source grounding is direct and comprehensive (5). No major issues. Accept.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis